STRATEGY STUDIO / NONPROFIT PEOPLE SEARCH

OKLAHOMA MEDICAL RESEARCH FOUNDATION: Form 990, tax year 2024

View the entire original 990 at ProPublica ↗

Organization
OKLAHOMA MEDICAL RESEARCH FOUNDATION (EIN 73-0580274)
Tax period
2024-07-01 to 2025-06-30
Filed
2026-05-15
IRS object ID
202641359349313249
Schema version
2024v5.1
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Return2026-05-15T15:54:04+00:00ReturnTs
Tax Period End2025-06-30TaxPeriodEndDt
Return Type990ReturnTypeCd
Tax Period Begin2024-07-01TaxPeriodBeginDt

Filer Filer

FieldValueIRS element (for citing)
EIN730580274EIN

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1Oklahoma Medical Research FoundationBusinessNameLine1Txt
FieldValueIRS element (for citing)
Business Name ControlOKLABusinessNameControlTxt
Phone4052717421PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line1825 NE 13th StreetAddressLine1Txt
CityOklahoma CityCityNm
State AbbreviationOKStateAbbreviationCd
ZIP73104ZIPCd

Business Officer BusinessOfficerGrp

FieldValueIRS element (for citing)
PersonTim HassenPersonNm
Person TitleVP and Chief Financial OfficerPersonTitleTxt
Phone4052717421PhoneNum
Signature2026-05-15SignatureDt
FieldValueIRS element (for citing)
Tax2024TaxYr
Build TS2025-03-06 01:10:19ZBuildTS

Form 990 IRS990

Principal Ofcr Business Name PrincipalOfcrBusinessName

FieldValueIRS element (for citing)
Business Name Line1Tim Hassen VP and CFOBusinessNameLine1Txt

US Address USAddress

FieldValueIRS element (for citing)
Address Line1825 NE 13th StreetAddressLine1Txt
CityOklahoma CityCityNm
State AbbreviationOKStateAbbreviationCd
ZIP73104ZIPCd
FieldValueIRS element (for citing)
Gross Receipts$267,452,700GrossReceiptsAmt
Group Return For AffiliatesfalseGroupReturnForAffiliatesInd
Organization501c3Yes (X)Organization501c3Ind
Website Addresswww.omrf.orgWebsiteAddressTxt
Type Of Organization CorpYes (X)TypeOfOrganizationCorpInd
Formation1946FormationYr
Legal Domicile StateOKLegalDomicileStateCd
Activity Or MissionOklahoma Medical Research Foundation (OMRF) is dedicated to developing a better understanding of and more effective treatments for human disease.ActivityOrMissionDesc
Voting Members Governing Body62VotingMembersGoverningBodyCnt
Voting Members Independent62VotingMembersIndependentCnt
Total Employee659TotalEmployeeCnt
Total Volunteers62TotalVolunteersCnt
Total Gross UBI$89TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm$0NetUnrelatedBusTxblIncmAmt
PY Contributions Grants$88,644,965PYContributionsGrantsAmt
CY Contributions Grants$86,153,223CYContributionsGrantsAmt
PY Program Service Revenue$29,301,960PYProgramServiceRevenueAmt
CY Program Service Revenue$32,877,905CYProgramServiceRevenueAmt
PY Investment Income$7,458,610PYInvestmentIncomeAmt
CY Investment Income$8,998,064CYInvestmentIncomeAmt
PY Other Revenue$6,926,766PYOtherRevenueAmt
CY Other Revenue$8,747,637CYOtherRevenueAmt
PY Total Revenue$132,332,301PYTotalRevenueAmt
CY Total Revenue$136,776,829CYTotalRevenueAmt
CY Grants And Similar Paid$0CYGrantsAndSimilarPaidAmt
CY Benefits Paid To Members$0CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid$51,893,083PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid$55,922,704CYSalariesCompEmpBnftPaidAmt
CY Total Prof Fndrsng Expns$0CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense$3,230,304CYTotalFundraisingExpenseAmt
PY Other Expenses$67,811,404PYOtherExpensesAmt
CY Other Expenses$70,554,283CYOtherExpensesAmt
PY Total Expenses$119,704,487PYTotalExpensesAmt
CY Total Expenses$126,476,987CYTotalExpensesAmt
PY Revenues Less Expenses$12,627,814PYRevenuesLessExpensesAmt
CY Revenues Less Expenses$10,299,842CYRevenuesLessExpensesAmt
Total Assets BOY$528,771,950TotalAssetsBOYAmt
Total Assets EOY$560,513,987TotalAssetsEOYAmt
Total Liabilities BOY$39,302,223TotalLiabilitiesBOYAmt
Total Liabilities EOY$34,404,489TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY$489,469,727NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY$526,109,498NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part IIIYes (X)InfoInScheduleOPartIIIInd
MissionOMRF is dedicated to developing a better understanding of more effective treatments for human disease.MissionDesc
Significant New Program SrvcfalseSignificantNewProgramSrvcInd
Significant ChangefalseSignificantChangeInd
Expense$47,419,059ExpenseAmt
Revenue$23,793,202RevenueAmt
DescArthritis and Clinical Immunology/Clinical Operations - OMRF continued to build on its national leadership in autoimmune disease research and care. In 2025, physicians in the foundation's clinics treated more than 3,000 patients living with conditions such as lupus, multiple sclerosis and rheumatoid arthritis. At the same time, OMRF expanded its portfolio of clinical trials, serving as a leading site for some of the first U.S. studies designed to prevent autoimmune diseases before symptoms appear. These trials focus on people at high risk of developing lupus or rheumatoid arthritis and aim to better understand how these illnesses begin - and how they might be delayed or stopped.Desc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

FieldValueIRS element (for citing)
Expense$11,214,388ExpenseAmt
Revenue$13,077,342RevenueAmt
DescAging and Metabolism Research Program - OMRF's Aging & Metabolism Research Program continued to advance research into how aging affects the body and how those changes might be slowed. The program welcomed a new investigator, Dr. David Hughes, whose work explores how cells recycle proteins to maintain healthy tissues. Program scientists also earned national recognition, with Dr. Sue Bodine named president-elect of the American Physiological Society and Dr. Benjamin Miller completing his term as president of the American Aging Association. Researchers secured new federal grants and training awards, performed public outreach on healthy aging and neurodegenerative disease, and launched a first-of-its-kind clinical trial examining why some older adults respond better to certain forms of exercise than others.Desc

Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp

FieldValueIRS element (for citing)
Expense$9,664,447ExpenseAmt
Revenue$10,827,654RevenueAmt
DescCardiovascular Biology Research Program - Scientists in OMRF's Cardiovascular Biology Research Program made discoveries that could reshape understanding of diseases affecting blood vessels and circulation. Dr. Courtney Griffin revealed new ways blood vessels can be damaged during conditions such as Tylenol overdose and diabetes-related eye disease, and she identified a potential strategy to protect delicate eye capillaries and preserve vision in early stages of disease. Meanwhile, Dr. Sathish Srinivasan discovered that malfunction of the body's lymphatic vessels may contribute to Crohn's disease, pointing to a possible new avenue for treatment.Desc

Prog Srvc Accom Acty Other ProgSrvcAccomActyOtherGrp

FieldValueIRS element (for citing)
Expense$48,805,337ExpenseAmt
Revenue$38,720,279RevenueAmt
DescOther program services include departments such as Cell Cycle and Cancer Biology, Genes and Human Disease, Center for Biomedical Data Sciences and other scientific and research support services.Desc
FieldValueIRS element (for citing)
Total Other Prog Srvc Expense$48,805,337TotalOtherProgSrvcExpenseAmt
Total Other Prog Srvc Revenue$38,720,279TotalOtherProgSrvcRevenueAmt
Total Program Service Expenses$117,103,231TotalProgramServiceExpensesAmt
Described In Section501c3Yes (true)DescribedInSection501c3Ind
Schedule B RequiredYes (true)ScheduleBRequiredInd
Political Campaign ActyfalsePoliticalCampaignActyInd
Lobbying ActivitiesYes (true)LobbyingActivitiesInd
Subject To Proxy TaxfalseSubjectToProxyTaxInd
Donor Advised FundfalseDonorAdvisedFundInd
Conservation EasementsfalseConservationEasementsInd
Collections Of ArtfalseCollectionsOfArtInd
Credit CounselingfalseCreditCounselingInd
Donor Rstr Or Quasi EndowmentsYes (true)DonorRstrOrQuasiEndowmentsInd
Report Land Building EquipmentYes (true)ReportLandBuildingEquipmentInd
Report Investments Other SecYes (true)ReportInvestmentsOtherSecInd
Report Program Related InvstfalseReportProgramRelatedInvstInd
Report Other AssetsYes (true)ReportOtherAssetsInd
Report Other LiabilitiesYes (true)ReportOtherLiabilitiesInd
Include FIN48 FootnoteYes (true)IncludeFIN48FootnoteInd
Independent Audit Fincl StmtYes (true)IndependentAuditFinclStmtInd
Consolidated Audit Fincl StmtYes (true)ConsolidatedAuditFinclStmtInd
School OperatingfalseSchoolOperatingInd
Foreign OfficefalseForeignOfficeInd
Foreign ActivitiesYes (true)ForeignActivitiesInd
More Than5000 K To OrgfalseMoreThan5000KToOrgInd
More Than5000 K To IndividualsfalseMoreThan5000KToIndividualsInd
Professional FundraisingfalseProfessionalFundraisingInd
Fundraising ActivitiesYes (true)FundraisingActivitiesInd
Gaming ActivitiesfalseGamingActivitiesInd
Operate HospitalfalseOperateHospitalInd
Grants To OrganizationsfalseGrantsToOrganizationsInd
Grants To IndividualsfalseGrantsToIndividualsInd
Schedule J RequiredYes (true)ScheduleJRequiredInd
Tax Exempt BondsYes (true)TaxExemptBondsInd
Invest Tax Exempt BondsfalseInvestTaxExemptBondsInd
Escrow AccountfalseEscrowAccountInd
On Behalf Of IssuerfalseOnBehalfOfIssuerInd
Engaged In Excess Benefit TransfalseEngagedInExcessBenefitTransInd
PY Excess Benefit TransfalsePYExcessBenefitTransInd
Loan OutstandingfalseLoanOutstandingInd
Grant To Related PersonfalseGrantToRelatedPersonInd
Business Rln With Org MemfalseBusinessRlnWithOrgMemInd
Business Rln With Fam MemfalseBusinessRlnWithFamMemInd
Business Rln With35 Ctrl EntfalseBusinessRlnWith35CtrlEntInd
Deductible Non Cash ContriYes (true)DeductibleNonCashContriInd
Deductible Art ContributionfalseDeductibleArtContributionInd
Terminate OperationsfalseTerminateOperationsInd
Partial LiquidationfalsePartialLiquidationInd
Disregarded EntityYes (true)DisregardedEntityInd
Related EntityfalseRelatedEntityInd
Related Organization Ctrl EntfalseRelatedOrganizationCtrlEntInd
Transaction With Control EntfalseTransactionWithControlEntInd
Trnsfr Exmpt Non Chrtbl Rltd OrgfalseTrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted PrtshpfalseActivitiesConductedPrtshpInd
Schedule O RequiredYes (true)ScheduleORequiredInd
IRP Document216IRPDocumentCnt
IRP Document W2 G0IRPDocumentW2GCnt
Backup Wthld ComplianceYes (true)BackupWthldComplianceInd
Employee659EmployeeCnt
Employment Tax Returns FiledYes (true)EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over LimitYes (true)UnrelatedBusIncmOverLimitInd
Form990 T FiledYes (true)Form990TFiledInd
Foreign Financial AccountfalseForeignFinancialAccountInd
Prohibited Tax Shelter TransfalseProhibitedTaxShelterTransInd
Taxable Party NotificationfalseTaxablePartyNotificationInd
Nondeductible ContributionsYes (true)NondeductibleContributionsInd
Nondeductible Contri DisclYes (true)NondeductibleContriDisclInd
Quid Pro Quo ContributionsYes (true)QuidProQuoContributionsInd
Quid Pro Quo Contri DisclYes (true)QuidProQuoContriDisclInd
Form8282 Property Disposed OffalseForm8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft CntrctfalseRcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft CntrctfalsePayPremiumsPrsnlBnftCntrctInd
Form8899 FiledindtrueForm8899Filedind
Form1098 C FiledYes (true)Form1098CFiledInd
Indoor Tanning ServicesfalseIndoorTanningServicesInd
Subj To Tax Rmnrtn Ex Prcht PymtfalseSubjToTaxRmnrtnExPrchtPymtInd
Subject To Excs Tax Net Invst IncfalseSubjectToExcsTaxNetInvstIncInd
Info In Schedule O Part VIYes (X)InfoInScheduleOPartVIInd
Governing Body Voting Members62GoverningBodyVotingMembersCnt
Independent Voting Member62IndependentVotingMemberCnt
Family Or Business RlnfalseFamilyOrBusinessRlnInd
Delegation Of Mgmt DutiesfalseDelegationOfMgmtDutiesInd
Change To Org DocumentsfalseChangeToOrgDocumentsInd
Material Diversion Or MisusefalseMaterialDiversionOrMisuseInd
Members Or StockholdersfalseMembersOrStockholdersInd
Election Of Board MembersfalseElectionOfBoardMembersInd
Decisions Subject To ApprovafalseDecisionsSubjectToApprovaInd
Minutes Of Governing BodyYes (true)MinutesOfGoverningBodyInd
Minutes Of CommitteesYes (true)MinutesOfCommitteesInd
Officer Mailing AddressfalseOfficerMailingAddressInd
Local ChaptersfalseLocalChaptersInd
Policies Reference ChaptersfalsePoliciesReferenceChaptersInd
Form990 Provided To Gvrn BodyYes (true)Form990ProvidedToGvrnBodyInd
Conflict Of Interest PolicyYes (true)ConflictOfInterestPolicyInd
Annual Disclosure Covered PrsnYes (true)AnnualDisclosureCoveredPrsnInd
Regular Monitoring EnfrcYes (true)RegularMonitoringEnfrcInd
Whistleblower PolicyYes (true)WhistleblowerPolicyInd
Document Retention PolicyYes (true)DocumentRetentionPolicyInd
Compensation Process CEOYes (true)CompensationProcessCEOInd
Compensation Process OtherYes (true)CompensationProcessOtherInd
Investment In Joint VenturefalseInvestmentInJointVentureInd
Written Policy Or ProcedurefalseWrittenPolicyOrProcedureInd
States Where Copy Of Return Is FldOKStatesWhereCopyOfReturnIsFldCd
Upon RequestYes (X)UponRequestInd
OtherYes (X)OtherInd

Books In Care Of Detail BooksInCareOfDetail

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1Tim Hassen VP and Chief Financial OfficerBusinessNameLine1Txt
FieldValueIRS element (for citing)
Phone4052717421PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line1825 NE 13th StreetAddressLine1Txt
CityOklahoma CityCityNm
State AbbreviationOKStateAbbreviationCd
ZIP73104ZIPCd

Form990 Part VII Section A Form990PartVIISectionAGrp (79 entries)

TitleTitleTxtAverage Hours Per WeekAverageHoursPerWeekRtIndividual Trustee Or DirectorIndividualTrusteeOrDirectorIndReportable Comp From OrgReportableCompFromOrgAmtReportable Comp From Rltd OrgReportableCompFromRltdOrgAmtOther CompensationOtherCompensationAmtOfficerOfficerIndKey EmployeeKeyEmployeeIndHighest Compensated EmployeeHighestCompensatedEmployeeInd
Ann Felton
Board Member1.0Yes (X)$0$0$0
Barbara Braught
Board Member1.0Yes (X)$0$0$0
Barry Pollard MD
Board Member1.0Yes (X)$0$0$0
Becky Switzer
Board Member1.0Yes (X)$0$0$0
Betsy Thorpe
Board Member1.0Yes (X)$0$0$0
Bill Anoatubby
Board Member1.0Yes (X)$0$0$0
Bill Hawley MD
Board Member1.0Yes (X)$0$0$0
Brett Jameson MD
Board Member1.0Yes (X)$0$0$0
Brooks Hall
Board Member1.0Yes (X)$0$0$0
Bruce Benbrook
Board Member1.0Yes (X)$0$0$0
Burns Hargis
Board Member1.0Yes (X)$0$0$0
Christy Everest
Board Member1.0Yes (X)$0$0$0
Claire Eagan
Board Member1.0Yes (X)$0$0$0
Cliff Hudson
Board Member1.0Yes (X)$0$0$0
Dan Little
Board Member1.0Yes (X)$0$0$0
David Rainbolt
Board Member1.0Yes (X)$0$0$0
Dee Replogle
Board Member1.0Yes (X)$0$0$0
Ellen Burgess
Board Member1.0Yes (X)$0$0$0
Gail Muncrief
Board Member1.0Yes (X)$0$0$0
Gerald Gamble
Board Member1.0Yes (X)$0$0$0
Greg Walton MD
Board Member1.0Yes (X)$0$0$0
Harrison Levy
Board Member1.0Yes (X)$0$0$0
Hiram Champlin
Board Member1.0Yes (X)$0$0$0
Jack McCarty
Board Member1.0Yes (X)$0$0$0
Jack Stark
Board Member1.0Yes (X)$0$0$0
Jacqui Haglund
Board Member1.0Yes (X)$0$0$0
Jerome Holmes
Board Member1.0Yes (X)$0$0$0
JII Boghetich
Board Member1.0Yes (X)$0$0$0
Jim Morris
Board Member1.0Yes (X)$0$0$0
John Griffin
Board Member1.0Yes (X)$0$0$0
John Saxon III MD
Board Member1.0Yes (X)$0$0$0
Judy Hatfield
Board Member1.0Yes (X)$0$0$0
Karin Holsted
Board Member1.0Yes (X)$0$0$0
Kimbra Scott
Board Member1.0Yes (X)$0$0$0
Lance Benham
Board Member1.0Yes (X)$0$0$0
Larry Nichols
Board Member1.0Yes (X)$0$0$0
Leigh Ann Albers
Board Member1.0Yes (X)$0$0$0
Len Cason
Board Member1.0Yes (X)$0$0$0
Lisa Dillingham
Board Member1.0Yes (X)$0$0$0
Mark Funke
Board Member1.0Yes (X)$0$0$0
Martin Bautista MD
Board Member1.0Yes (X)$0$0$0
Mautra Jones EdD
Board Member1.0Yes (X)$0$0$0
Meg Salyer
Board Member1.0Yes (X)$0$0$0
Michael Cawley
Board Member1.0Yes (X)$0$0$0
Mindy Mahaney
Board Member1.0Yes (X)$0$0$0
Pat Rooney
Board Member1.0Yes (X)$0$0$0
Paul Schulte
Board Member1.0Yes (X)$0$0$0
Rainey Williams Jr
Board Member1.0Yes (X)$0$0$0
Ramsey Drake
Board Member1.0Yes (X)$0$0$0
Randy Brown MD
Board Member1.0Yes (X)$0$0$0
Randy Hogan
Board Member1.0Yes (X)$0$0$0
Rebecca Patten
Board Member1.0Yes (X)$0$0$0
Richard Parry
Board Member1.0Yes (X)$0$0$0
Ronnie Irani
Board Member1.0Yes (X)$0$0$0
Sarah Yauk
Board Member1.0Yes (X)$0$0$0
Sharon Bell
Board Member1.0Yes (X)$0$0$0
Sherri Lance
Board Member1.0Yes (X)$0$0$0
Steven Taylor
Board Member1.0Yes (X)$0$0$0
Terence Kern
Board Member1.0Yes (X)$0$0$0
Tricia Everest
Board Member1.0Yes (X)$0$0$0
Virginia Groendyke
Board Member1.0Yes (X)$0$0$0
Walt Duncan IV
Board Member1.0Yes (X)$0$0$0
Adam Cohen
SVP and General Counsel50.0$326,153$0$68,468Yes (X)
Andrew Weyrich PhD
President and CEO50.0$818,633$0$50,763Yes (X)
Courtney Greenwood
VP of Human Resources50.0$207,544$0$38,327Yes (X)
Courtney Griffin PhD
VP of Research50.0$307,420$0$63,830Yes (X)
Judith James
EVP and Chief Medical Officer50.0$876,648$0$139,926Yes (X)
Lisa Day
VP of Government Relations and Advocacy50.0$210,081$0$43,533Yes (X)
Penny Voss
VP of Philanthropy and Community Relations50.0$270,186$0$60,801Yes (X)
Tim Hassen
VP and Chief Financial Officer50.0$291,289$0$74,490Yes (X)
Benjamin Miller PhD
Program Chair, Aging and Metabolism50.0$175,939$0$20,325Yes (X)
Gabriel Pardo MD
Professor Clinical Neurology, Arthritis and Clinical Immunology50.0$410,861$0$53,100Yes (X)
Lijun Xia PhD
Program Chair, Cardiovascular Biology50.0$304,307$0$64,952Yes (X)
Patrick Gaffney MD
Program Chair, Genes and Human Disease50.0$277,651$0$55,744Yes (X)
Chelsea Berkley MD
Clinical Assistant Professor, Arthritis and Clinical Immunology50.0$250,814$0$30,558Yes (X)
Florea Lupu PhD
Professor, Cardiovascular Biology50.0$342,973$0$40,999Yes (X)
Joel Guthridge PhD
Associate Professor, Arthritis and Clinical Immunology50.0$252,039$0$31,301Yes (X)
Swapan Nath PhD
Professor, Arthritis and Clinical Immunology50.0$308,762$0$43,590Yes (X)
Yang Mao-Draayer PhD
Professor Clinical Neurology, Arthritis and Clinical Immunology50.0$290,487$0$32,892Yes (X)
FieldValueIRS element (for citing)
Total Reportable Comp From Org$5,921,787TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org$0TotReportableCompRltdOrgAmt
Total Other Compensation$913,599TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K90IndivRcvdGreaterThan100KCnt
Former Ofcr Employees ListedfalseFormerOfcrEmployeesListedInd
Total Comp Greater Than150 KYes (true)TotalCompGreaterThan150KInd
Compensation From Other SrcsfalseCompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp (5 entries)

Address Line1ContractorAddress/USAddress/AddressLine1TxtAddress Line2ContractorAddress/USAddress/AddressLine2TxtCityContractorAddress/USAddress/CityNmState AbbreviationContractorAddress/USAddress/StateAbbreviationCdZIPContractorAddress/USAddress/ZIPCdServicesServicesDescCompensationCompensationAmt
Infusion Management LLC
11233 Shadow Creek PwkySuite 303PearlandTX77584Infusion Management Services$24,643,904
Aramark
24863 Network PlChicagoIL606731248HouseKeeping Services$682,547
Miles Architecture LLC
865 Research PkwySuite 100Oklahoma CityOK73104Architectural services$502,682
Beck Associates Architects PLLC
110 W 7th StSte 710TulsaOK74119Architectural Services$233,590
CapTrust Partners LLC
4208 Six Forks RdSte 1700RaleighNC27609Investment Management Services$150,961
FieldValueIRS element (for citing)
Cntrct Rcvd Greater Than100 K5CntrctRcvdGreaterThan100KCnt
Federated Campaigns$88,481FederatedCampaignsAmt
Fundraising$1,146,963FundraisingAmt
Government Grants$53,057,578GovernmentGrantsAmt
All Other Contributions$31,860,201AllOtherContributionsAmt
Noncash Contributions$476,585NoncashContributionsAmt
Total Contributions$86,153,223TotalContributionsAmt

Program Service Revenue ProgramServiceRevenueGrp

FieldValueIRS element (for citing)
DescClinic RevenueDesc
Business621990BusinessCd
Total Revenue Column$32,877,905TotalRevenueColumnAmt
Related Or Exempt Func Income$32,877,905RelatedOrExemptFuncIncomeAmt

Total Oth Program Service Rev TotalOthProgramServiceRevGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt
Related Or Exempt Func Income$0RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$0ExclusionAmt
FieldValueIRS element (for citing)
Total Program Service Revenue$32,877,905TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

FieldValueIRS element (for citing)
Total Revenue Column$12,047,510TotalRevenueColumnAmt
Unrelated Business Revenue$447UnrelatedBusinessRevenueAmt
Exclusion$12,047,063ExclusionAmt

Incm From Invest Bond Proceeds IncmFromInvestBondProceedsGrp

FieldValueIRS element (for citing)
Total Revenue Column$146,231TotalRevenueColumnAmt
Exclusion$146,231ExclusionAmt

Royalties Revenue RoyaltiesRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$5,295,608TotalRevenueColumnAmt
Related Or Exempt Func Income$3,182,242RelatedOrExemptFuncIncomeAmt
Exclusion$2,113,366ExclusionAmt

Gross Rents GrossRentsGrp

FieldValueIRS element (for citing)
Real$467,781RealAmt

Rental Income Or Loss RentalIncomeOrLossGrp

FieldValueIRS element (for citing)
Real$467,781RealAmt
Personal$0PersonalAmt

Net Rental Income Or Loss NetRentalIncomeOrLossGrp

FieldValueIRS element (for citing)
Total Revenue Column$467,781TotalRevenueColumnAmt
Exclusion$467,781ExclusionAmt

Gross Amount Sales Assets GrossAmountSalesAssetsGrp

FieldValueIRS element (for citing)
Securities$127,219,512SecuritiesAmt
Other$20,871OtherAmt

Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp

FieldValueIRS element (for citing)
Securities$130,417,433SecuritiesAmt
Other$18,627OtherAmt

Gain Or Loss GainOrLossGrp

FieldValueIRS element (for citing)
Securities-$3,197,921SecuritiesAmt
Other$2,244OtherAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

FieldValueIRS element (for citing)
Total Revenue Column-$3,195,677TotalRevenueColumnAmt
Unrelated Business Revenue-$358UnrelatedBusinessRevenueAmt
Exclusion-$3,195,319ExclusionAmt
FieldValueIRS element (for citing)
Fundraising Gross Income$69,600FundraisingGrossIncomeAmt
Contri Rpt Fundraising Event$1,146,963ContriRptFundraisingEventAmt
Fundraising Direct Expenses$239,811FundraisingDirectExpensesAmt

Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp

FieldValueIRS element (for citing)
Total Revenue Column-$170,211TotalRevenueColumnAmt
Exclusion-$170,211ExclusionAmt

Other Revenue Misc OtherRevenueMiscGrp (2 entries)

DescDescBusinessBusinessCdTotal Revenue ColumnTotalRevenueColumnAmtRelated Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmtExclusionExclusionAmt
Laboratory Income621500$2,660,133$2,660,133
Cafe Income722514$494,326$494,326

Miscellaneous Revenue MiscellaneousRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt
Related Or Exempt Func Income$0RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$0ExclusionAmt
FieldValueIRS element (for citing)
Other Revenue Total$3,154,459OtherRevenueTotalAmt

Total Revenue TotalRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$136,776,829TotalRevenueColumnAmt
Related Or Exempt Func Income$38,720,280RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$89UnrelatedBusinessRevenueAmt
Exclusion$11,903,237ExclusionAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

FieldValueIRS element (for citing)
Total$4,476,713TotalAmt
Program Services$3,720,498ProgramServicesAmt
Management And General$486,029ManagementAndGeneralAmt
Fundraising$270,186FundraisingAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

FieldValueIRS element (for citing)
Total$38,100,870TotalAmt
Program Services$35,162,949ProgramServicesAmt
Management And General$1,595,136ManagementAndGeneralAmt
Fundraising$1,342,785FundraisingAmt

Pension Plan Contributions PensionPlanContributionsGrp

FieldValueIRS element (for citing)
Total$3,223,980TotalAmt
Program Services$2,944,260ProgramServicesAmt
Management And General$157,586ManagementAndGeneralAmt
Fundraising$122,134FundraisingAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

FieldValueIRS element (for citing)
Total$7,231,058TotalAmt
Program Services$6,304,721ProgramServicesAmt
Management And General$706,747ManagementAndGeneralAmt
Fundraising$219,590FundraisingAmt

Payroll Taxes PayrollTaxesGrp

FieldValueIRS element (for citing)
Total$2,890,083TotalAmt
Program Services$2,639,333ProgramServicesAmt
Management And General$141,265ManagementAndGeneralAmt
Fundraising$109,485FundraisingAmt

Fees For Services Legal FeesForServicesLegalGrp

FieldValueIRS element (for citing)
Total$196,099TotalAmt
Program Services$144,683ProgramServicesAmt
Management And General$51,416ManagementAndGeneralAmt

Fees For Services Accounting FeesForServicesAccountingGrp

FieldValueIRS element (for citing)
Total$161,163TotalAmt
Management And General$161,163ManagementAndGeneralAmt

Fees For Services Lobbying FeesForServicesLobbyingGrp

FieldValueIRS element (for citing)
Total$83,574TotalAmt
Management And General$83,574ManagementAndGeneralAmt

Fees For Services Other FeesForServicesOtherGrp

FieldValueIRS element (for citing)
Total$3,477,172TotalAmt
Program Services$3,477,172ProgramServicesAmt
Management And General$0ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Office Expenses OfficeExpensesGrp

FieldValueIRS element (for citing)
Total$844,307TotalAmt
Program Services$392,323ProgramServicesAmt
Management And General$75,696ManagementAndGeneralAmt
Fundraising$376,288FundraisingAmt

Information Technology InformationTechnologyGrp

FieldValueIRS element (for citing)
Total$2,324,172TotalAmt
Program Services$1,763,854ProgramServicesAmt
Management And General$349,226ManagementAndGeneralAmt
Fundraising$211,092FundraisingAmt

Occupancy OccupancyGrp

FieldValueIRS element (for citing)
Total$5,879,636TotalAmt
Program Services$4,802,835ProgramServicesAmt
Management And General$1,076,684ManagementAndGeneralAmt
Fundraising$117FundraisingAmt

Travel TravelGrp

FieldValueIRS element (for citing)
Total$921,416TotalAmt
Program Services$856,868ProgramServicesAmt
Management And General$44,581ManagementAndGeneralAmt
Fundraising$19,967FundraisingAmt

Conferences Meetings ConferencesMeetingsGrp

FieldValueIRS element (for citing)
Total$276,762TotalAmt
Program Services$240,479ProgramServicesAmt
Management And General$393ManagementAndGeneralAmt
Fundraising$35,890FundraisingAmt

Interest InterestGrp

FieldValueIRS element (for citing)
Total$181,426TotalAmt
Program Services$175,904ProgramServicesAmt
Management And General$5,522ManagementAndGeneralAmt

Depreciation Depletion DepreciationDepletionGrp

FieldValueIRS element (for citing)
Total$8,633,668TotalAmt
Program Services$8,300,484ProgramServicesAmt
Management And General$333,184ManagementAndGeneralAmt

Insurance InsuranceGrp

FieldValueIRS element (for citing)
Total$680,401TotalAmt
Program Services$502,004ProgramServicesAmt
Management And General$178,397ManagementAndGeneralAmt

Other Expenses OtherExpensesGrp (4 entries)

DescDescTotalTotalAmtProgram ServicesProgramServicesAmtManagement And GeneralManagementAndGeneralAmtFundraisingFundraisingAmt
Subcontracts$31,853,325$31,853,325
Lab supplies$8,871,167$8,871,167
Other$3,482,784$2,287,627$682,755$512,402
Inhouse$1,896,752$1,872,285$14,099$10,368

All Other Expenses AllOtherExpensesGrp

FieldValueIRS element (for citing)
Total$790,459TotalAmt
Program Services$790,459ProgramServicesAmt
Management And General$0ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Total Functional Expenses TotalFunctionalExpensesGrp

FieldValueIRS element (for citing)
Total$126,476,987TotalAmt
Program Services$117,103,230ProgramServicesAmt
Management And General$6,143,453ManagementAndGeneralAmt
Fundraising$3,230,304FundraisingAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

FieldValueIRS element (for citing)
BOY$3,640BOYAmt
EOY$2,400EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

FieldValueIRS element (for citing)
BOY$44,170,006BOYAmt
EOY$45,812,921EOYAmt

Pledges And Grants Receivable PledgesAndGrantsReceivableGrp

FieldValueIRS element (for citing)
BOY$14,620,131BOYAmt
EOY$16,092,286EOYAmt

Accounts Receivable AccountsReceivableGrp

FieldValueIRS element (for citing)
BOY$9,054,128BOYAmt
EOY$8,899,916EOYAmt

Receivables From Officers Etc ReceivablesFromOfficersEtcGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Rcvbl From Disqualified Prsn RcvblFromDisqualifiedPrsnGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Oth Notes Loans Receivable Net OthNotesLoansReceivableNetGrp

FieldValueIRS element (for citing)
BOY$79,411BOYAmt
EOY$91,578EOYAmt

Inventories For Sale Or Use InventoriesForSaleOrUseGrp

FieldValueIRS element (for citing)
BOY$1,174,683BOYAmt
EOY$898,990EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

FieldValueIRS element (for citing)
BOY$1,008,212BOYAmt
EOY$768,084EOYAmt
FieldValueIRS element (for citing)
Land Bldg Equip Cost Or Other Bss$255,778,407LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec$167,541,156LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

FieldValueIRS element (for citing)
BOY$85,631,955BOYAmt
EOY$88,237,251EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

FieldValueIRS element (for citing)
BOY$177,316,130BOYAmt
EOY$192,830,394EOYAmt

Investments Other Securities InvestmentsOtherSecuritiesGrp

FieldValueIRS element (for citing)
BOY$32,687,772BOYAmt
EOY$36,177,302EOYAmt

Investments Program Related InvestmentsProgramRelatedGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt

Other Assets Total OtherAssetsTotalGrp

FieldValueIRS element (for citing)
BOY$163,025,882BOYAmt
EOY$170,702,865EOYAmt

Total Assets TotalAssetsGrp

FieldValueIRS element (for citing)
BOY$528,771,950BOYAmt
EOY$560,513,987EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

FieldValueIRS element (for citing)
BOY$18,280,141BOYAmt
EOY$16,954,218EOYAmt

Deferred Revenue DeferredRevenueGrp

FieldValueIRS element (for citing)
BOY$2,838,255BOYAmt
EOY$1,833,419EOYAmt

Tax Exempt Bond Liabilities TaxExemptBondLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$7,875,000BOYAmt
EOY$4,765,000EOYAmt

Loans From Officers Directors LoansFromOfficersDirectorsGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Other Liabilities OtherLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$10,308,827BOYAmt
EOY$10,851,852EOYAmt

Total Liabilities TotalLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$39,302,223BOYAmt
EOY$34,404,489EOYAmt

No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp

FieldValueIRS element (for citing)
BOY$195,929,685BOYAmt
EOY$206,601,526EOYAmt

Donor Restriction Net Assets DonorRestrictionNetAssetsGrp

FieldValueIRS element (for citing)
BOY$293,540,042BOYAmt
EOY$319,507,972EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$489,469,727BOYAmt
EOY$526,109,498EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$528,771,950BOYAmt
EOY$560,513,987EOYAmt
FieldValueIRS element (for citing)
Info In Schedule O Part XIYes (X)InfoInScheduleOPartXIInd
Reconcilation Revenue Expnss$10,299,842ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst$18,841,615NetUnrlzdGainsLossesInvstAmt
Other Changes In Net Assets$7,498,314OtherChangesInNetAssetsAmt
Method Of Accounting AccrualYes (X)MethodOfAccountingAccrualInd
Accountant Compile Or ReviewfalseAccountantCompileOrReviewInd
FS AuditedYes (true)FSAuditedInd
Audit CommitteeYes (true)AuditCommitteeInd
Federal Grant Audit RequiredYes (true)FederalGrantAuditRequiredInd
Federal Grant Audit PerformedYes (true)FederalGrantAuditPerformedInd

Schedule A IRS990ScheduleA

FieldValueIRS element (for citing)
Public Organization170Yes (X)PublicOrganization170Ind

Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$91,435,276CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$70,293,950CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$71,342,417CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$88,644,965CurrentTaxYearMinus1YearAmt
Current Tax Year$86,153,223CurrentTaxYearAmt
Total$407,869,831TotalAmt

Tax Rev Levied Orgnztnl Bnft170 TaxRevLeviedOrgnztnlBnft170Grp

FieldValueIRS element (for citing)
Total$0TotalAmt

Govt Furn Srvc Fclts Vl170 GovtFurnSrvcFcltsVl170Grp

FieldValueIRS element (for citing)
Total$0TotalAmt

Total Calendar Year170 TotalCalendarYear170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$91,435,276CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$70,293,950CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$71,342,417CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$88,644,965CurrentTaxYearMinus1YearAmt
Current Tax Year$86,153,223CurrentTaxYearAmt
Total$407,869,831TotalAmt
FieldValueIRS element (for citing)
Substantial Contributors Tot$71,220,252SubstantialContributorsTotAmt
Public Support Total170$336,649,579PublicSupportTotal170Amt

Gross Investment Income170 GrossInvestmentIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$8,109,982CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$15,219,254CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$11,853,866CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$31,741,457CurrentTaxYearMinus1YearAmt
Current Tax Year$14,774,441CurrentTaxYearAmt
Total$81,699,000TotalAmt

Unrelated Business Net Incm170 UnrelatedBusinessNetIncm170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$10,725CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$51,456CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$0CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$0CurrentTaxYearMinus1YearAmt
Current Tax Year$0CurrentTaxYearAmt
Total$62,181TotalAmt

Other Income170 OtherIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$158,503CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$260,020CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$425,851CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$526,475CurrentTaxYearMinus1YearAmt
Current Tax Year$563,926CurrentTaxYearAmt
Total$1,934,775TotalAmt
FieldValueIRS element (for citing)
Total Support$491,565,787TotalSupportAmt
Gross Receipts Rltd Activities$167,488,741GrossReceiptsRltdActivitiesAmt
Public Support CY1700.68485PublicSupportCY170Pct
Public Support PY1700.68282PublicSupportPY170Pct
Thirty Thr Pct Suprt Tests CY170Yes (X)ThirtyThrPctSuprtTestsCY170Ind

Form990 Schedule A Part VI Form990ScheduleAPartVIGrp (2 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
Schedule A, Part II, Line 10 Schedule A, Part II, Line 10Other income includes cafeteria sales as well as fundraising income that was not included in contributions.
Schedule A, Part II, Line 10 Other IncomeDESCRIPTION - , COLUMN A - 158503.0, COLUMN B - 260020.0, COLUMN C - 425851.0, COLUMN D - 526475.0, COLUMN E - 563926.0, COLUMN F - 1934775.0;

Schedule B IRS990ScheduleB

Contributor Information ContributorInformationGrp

FieldValueIRS element (for citing)
ContributorRESTRICTEDContributorNum

Contributor Business Name ContributorBusinessName

FieldValueIRS element (for citing)
Business Name Line1RESTRICTEDBusinessNameLine1

Contributor US Address ContributorUSAddress

FieldValueIRS element (for citing)
Address Line1RESTRICTEDAddressLine1
Address Line2RESTRICTEDAddressLine2
CityRESTRICTEDCity
StateRESTRICTEDState
ZIP CodeRESTRICTEDZIPCode
FieldValueIRS element (for citing)
Total ContributionsRESTRICTEDTotalContributionsAmt

Schedule C IRS990ScheduleC

FieldValueIRS element (for citing)
VolunteersfalseVolunteersInd
Paid Staff Or ManagementYes (true)PaidStaffOrManagementInd
Media AdvertisementsfalseMediaAdvertisementsInd
Mailings MembersfalseMailingsMembersInd
Publications Or BroadcastfalsePublicationsOrBroadcastInd
Grants Other OrganizationsfalseGrantsOtherOrganizationsInd
Direct Contact LegislatorsYes (true)DirectContactLegislatorsInd
Direct Contact Legislators$491,506DirectContactLegislatorsAmt
Rallies DemonstrationsfalseRalliesDemonstrationsInd
Other ActivitiesfalseOtherActivitiesInd
Total Lobbying Expenditures$491,506TotalLobbyingExpendituresAmt
Not Described Section501c3falseNotDescribedSection501c3Ind

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceSchedule C, Part II-B, Line 1 DETAILED DESCRIPTION OF THE LOBBYING ACTIVITYFormAndLineReferenceDesc
ExplanationThe Foundation's lobbying activities entail monitoring proposed legislation and educating legislators and their staffs about the Foundation, medical research and the impact of proposed legislation on medical research and the Foundation.ExplanationTxt

Schedule D IRS990ScheduleD

CY Endwmt Fund CYEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$197,304,412BeginningYearBalanceAmt
Contributions$630,484ContributionsAmt
Investment Earnings Or Losses$24,937,288InvestmentEarningsOrLossesAmt
Other Expenditures$8,300,000OtherExpendituresAmt
End Year Balance$214,572,184EndYearBalanceAmt

CY Minus1 Yr Endwmt Fund CYMinus1YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$177,673,255BeginningYearBalanceAmt
Contributions$1,162,889ContributionsAmt
Investment Earnings Or Losses$25,868,268InvestmentEarningsOrLossesAmt
Other Expenditures$7,400,000OtherExpendituresAmt
End Year Balance$197,304,412EndYearBalanceAmt

CY Minus2 Yr Endwmt Fund CYMinus2YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$158,042,345BeginningYearBalanceAmt
Contributions$7,689,037ContributionsAmt
Investment Earnings Or Losses$17,641,873InvestmentEarningsOrLossesAmt
Other Expenditures$5,700,000OtherExpendituresAmt
End Year Balance$177,673,255EndYearBalanceAmt

CY Minus3 Yr Endwmt Fund CYMinus3YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$169,632,776BeginningYearBalanceAmt
Contributions$12,453,227ContributionsAmt
Investment Earnings Or Losses-$18,843,658InvestmentEarningsOrLossesAmt
Other Expenditures$5,200,000OtherExpendituresAmt
End Year Balance$158,042,345EndYearBalanceAmt

CY Minus4 Yr Endwmt Fund CYMinus4YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$116,281,093BeginningYearBalanceAmt
Contributions$18,987,421ContributionsAmt
Investment Earnings Or Losses$39,164,262InvestmentEarningsOrLossesAmt
Grants Or Scholarships$0GrantsOrScholarshipsAmt
Other Expenditures$4,800,000OtherExpendituresAmt
Administrative Expenses$0AdministrativeExpensesAmt
End Year Balance$169,632,776EndYearBalanceAmt
FieldValueIRS element (for citing)
Board Designated Balance EOY0.3423BoardDesignatedBalanceEOYPct
Prmnnt Endowment Balance EOY0.308PrmnntEndowmentBalanceEOYPct
Term Endowment Balance EOY0.3497TermEndowmentBalanceEOYPct
Endowments Held Unrelated OrgYes (true)EndowmentsHeldUnrelatedOrgInd
Endowments Held Related OrgfalseEndowmentsHeldRelatedOrgInd

Land LandGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$4,080,847OtherCostOrOtherBasisAmt
Book Value$4,080,847BookValueAmt

Buildings BuildingsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$193,623,830OtherCostOrOtherBasisAmt
Depreciation$133,140,968DepreciationAmt
Book Value$60,482,862BookValueAmt

Equipment EquipmentGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$53,745,331OtherCostOrOtherBasisAmt
Depreciation$33,892,034DepreciationAmt
Book Value$19,853,297BookValueAmt

Other Land Buildings OtherLandBuildingsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$4,328,399OtherCostOrOtherBasisAmt
Depreciation$508,154DepreciationAmt
Book Value$3,820,245BookValueAmt
FieldValueIRS element (for citing)
Total Book Value Land Buildings$88,237,251TotalBookValueLandBuildingsAmt

Other Securities OtherSecuritiesGrp (3 entries)

DescDescBook ValueBookValueAmtMethod ValuationMethodValuationCd
Closely-held equity interests
Financial derivatives
Other securites$36,177,302F
FieldValueIRS element (for citing)
Total Book Value Securities$36,177,302TotalBookValueSecuritiesAmt

Other Assets Org OtherAssetsOrgGrp (8 entries)

DescDescBook ValueBookValueAmt
Funds held in trust by others$158,811,072
Wills and Bequests$2,168,231
Cash Surrender Value of Life Insurance$8,704,924
Debt Issue Costs$26,617
Deposits$708,813
Accrued Interest Receivable$217,568
Assets Held for Sale$65,520
Minerals$120
FieldValueIRS element (for citing)
Total Book Value Other Assets$170,702,865TotalBookValueOtherAssetsAmt

Other Liabilities Org OtherLiabilitiesOrgGrp (4 entries)

DescDescAmtAmt
Federal Income Taxes
Postretirement Benefits and Deferred Comp$10,450,880
Split Interest Agreements$76,488
Long-term Lease Liability$324,484
FieldValueIRS element (for citing)
Total Liability$10,851,852TotalLiabilityAmt
Footnote TextYes (X)FootnoteTextInd
Total Rev Etc Audited Fincl Stmt$163,116,758TotalRevEtcAuditedFinclStmtAmt
Net Unrealized Gains Invst$18,841,615NetUnrealizedGainsInvstAmt
Other Revenue$7,498,314OtherRevenueAmt
Revenue Not Reported$26,339,929RevenueNotReportedAmt
Revenue Subtotal$136,776,829RevenueSubtotalAmt
Other Revenues Not Included$0OtherRevenuesNotIncludedAmt
Revenue Not Reported Fincl Stmt$0RevenueNotReportedFinclStmtAmt
Total Revenue Per Form990$136,776,829TotalRevenuePerForm990Amt
Tot Expns Etc Audited Fincl Stmt$126,476,987TotExpnsEtcAuditedFinclStmtAmt
Other Expenses Included$0OtherExpensesIncludedAmt
Expenses Not Reported$0ExpensesNotReportedAmt
Expenses Subtotal$126,476,987ExpensesSubtotalAmt
Other Expenses Not Included$0OtherExpensesNotIncludedAmt
Expenses Not Rpt Fincl Stmt$0ExpensesNotRptFinclStmtAmt
Total Expenses Per Form990$126,476,987TotalExpensesPerForm990Amt

Supplemental Information Detail SupplementalInformationDetail (4 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
Schedule D, Part XI, Line 2(d)Includes change in fair value of funds held in trust by others of $7,618,096 as well as pension related changes other than net periodic pension costs of $(119,782).
Schedule D, Part V, Line 4 Intended uses of endowment fundsThe Foundation's endowment consists of individual funds established to provide the Foundation with funding in perpetuity.
Schedule D, Part X, Line 2 FIN 48 (ASC 740) footnoteThe Foundation is a public foundation exempt from federal income tax under section 501(c)(3) of the internal revenue code except for amounts relating to unrelated business income. There were no known material unrelated business income taxes incurred in 2025 and accordingly, no provision for income taxes has been made in these financial statements. Management has reviewed the Foundation's tax position and concluded that there are no uncertain tax positions that require accrual in the consolidated financial statements or disclosure in the footnotes to be in compliance with authoritative literature. Generally, the Foundation is no longer subject to income tax examination by federal, state or local tax authorities for years prior to 2022. The statute of limitations will remain open for both federal and state purposes for any returns not filed.
Schedule D, Part XI, Line 2(d) Other revenues in audited financial statements not in form 990CHANGES IN FAIR VALUE OF FUNDS HELD IN TRUST - 7618096 PENSION RELATED CHANGES OTHER THAN NET PERIODIC PENSION COSTS - -119782

Schedule F IRS990ScheduleF

Account Activities Outside US AccountActivitiesOutsideUSGrp (8 entries)

RegionRegionTxtOfficesOfficesCntEmployeeEmployeeCntType Of Activities ConductedTypeOfActivitiesConductedTxtRegion Total ExpendituresRegionTotalExpendituresAmtSpecific Services ProvidedSpecificServicesProvidedTxt
Europe (Including Iceland and Greenland)031Conference Travel$68,172
Europe (Including Iceland and Greenland)09Program Services$12,846Student Program
North America (Canada & Mexico only)014Conference Travel$26,900
South Asia01Conference Travel$3,104
South America02Conference Travel$5,610
East Asia and the Pacific04Conference Travel$15,155
North America (Canada & Mexico only)00Investments$2,255,762
Central America and the Caribbean00Investments$15,988,158
FieldValueIRS element (for citing)
Subtotal Offices0SubtotalOfficesCnt
Subtotal Employees61SubtotalEmployeesCnt
Continuation Total Office0ContinuationTotalOfficeCnt
Continuation Total Employee0ContinuationTotalEmployeeCnt
Total Office0TotalOfficeCnt
Total Employee61TotalEmployeeCnt
Subtotal Spent$18,375,707SubtotalSpentAmt
Continuation Spent$0ContinuationSpentAmt
Total Spent$18,375,707TotalSpentAmt
Transfer To Foreign CorpYes (true)TransferToForeignCorpInd
Interest In Foreign TrustfalseInterestInForeignTrustInd
Foreign Corp OwnershipfalseForeignCorpOwnershipInd
Passive Foreign Investmest CoYes (true)PassiveForeignInvestmestCoInd
Foreign PartnershipYes (true)ForeignPartnershipInd
Boycott CountriesfalseBoycottCountriesInd

Supplemental Information Detail SupplementalInformationDetail (2 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
Schedule F, Part I, Line 3 Method used to account for expenditures on org's financial statementsCENTRAL AMERICA AND THE CARIBBEAN-Accrual; EAST ASIA AND THE PACIFIC-Accrual; EUROPE (INCLUDING ICELAND AND GREENLAND)-Accrual; NORTH AMERICA (CANADA & MEXICO ONLY)-Accrual; SOUTH AMERICA-Accrual; SOUTH ASIA-Accrual
Schedule F, Part VProgram service activity in all regions includes scientists attending and/or speaking at scientific conferences and collaborations. OMRF does not maintain ongoing operations in foreign jurisdictions, however the Foundation's scientists do travel to various scientific conferences in other countries to share in scientific discoveries, as well as to learn from other scientists across the world.

Schedule G IRS990ScheduleG

Fundraising Event Information FundraisingEventInformationGrp

FieldValueIRS element (for citing)
Event1241 EVENTEvent1Nm
Gross Receipts Event1$688,563GrossReceiptsEvent1Amt
Charitable Contri Event1$634,563CharitableContriEvent1Amt
Gross Revenue Event1$54,000GrossRevenueEvent1Amt
Rent Facility Costs Event1$30,400RentFacilityCostsEvent1Amt
Food And Beverage Event1$20,282FoodAndBeverageEvent1Amt
Entertainment Event1$87,850EntertainmentEvent1Amt
Other Direct Expenses Event1$60,523OtherDirectExpensesEvent1Amt
Event2MS DINNEREvent2Nm
Gross Receipts Event2$528,000GrossReceiptsEvent2Amt
Charitable Contri Event2$512,400CharitableContriEvent2Amt
Gross Revenue Event2$15,600GrossRevenueEvent2Amt
Rent Facility Costs Event2$1,500RentFacilityCostsEvent2Amt
Food And Beverage Event2$18,660FoodAndBeverageEvent2Amt
Entertainment Event2$11,295EntertainmentEvent2Amt
Other Direct Expenses Event2$9,301OtherDirectExpensesEvent2Amt
Gross Revenue Other Events$0GrossRevenueOtherEventsAmt
Gross Receipts Total$1,216,563GrossReceiptsTotalAmt
Charitable Contributions Tot$1,146,963CharitableContributionsTotAmt
Gross Revenue Total Events$69,600GrossRevenueTotalEventsAmt
Rent Fclty Costs Total Events$31,900RentFcltyCostsTotalEventsAmt
Food And Beverage Total Events$38,942FoodAndBeverageTotalEventsAmt
Entertainment Total Events$99,145EntertainmentTotalEventsAmt
Oth Direct Expnss Total Events$69,824OthDirectExpnssTotalEventsAmt
Direct Expense Summary Events$239,811DirectExpenseSummaryEventsAmt
Net Income Summary-$170,211NetIncomeSummaryAmt

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
First Class Or Charter TravelYes (X)FirstClassOrCharterTravelInd
Travel For CompanionsYes (X)TravelForCompanionsInd
Idemnification Gross Up PmtsYes (X)IdemnificationGrossUpPmtsInd
Written Policy Ref T And E ExpnssYes (true)WrittenPolicyRefTAndEExpnssInd
Substantiation RequiredYes (true)SubstantiationRequiredInd
Compensation CommitteeYes (X)CompensationCommitteeInd
Independent ConsultantYes (X)IndependentConsultantInd
Form990 Of Other OrganizationsYes (X)Form990OfOtherOrganizationsInd
Compensation SurveyYes (X)CompensationSurveyInd
Board Or Committee ApprovalYes (X)BoardOrCommitteeApprovalInd
Severance PaymentfalseSeverancePaymentInd
Supplemental Nonqual Rtr PlanYes (true)SupplementalNonqualRtrPlanInd
Equity Based Comp ArrngmfalseEquityBasedCompArrngmInd
Comp Based On Revenue Of Flng OrgfalseCompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related OrgsfalseCompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng OrgfalseCompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd OrgsfalseCompBsdNetEarnsRltdOrgsInd
Any Non Fixed PaymentsYes (true)AnyNonFixedPaymentsInd
Initial Contract ExceptionfalseInitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (17 entries)

TitleTitleTxtBase Compensation Filing OrgBaseCompensationFilingOrgAmtCompensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmtBonus Filing OrganizationBonusFilingOrganizationAmountBonus Related OrganizationsBonusRelatedOrganizationsAmtOther Compensation Filing OrgOtherCompensationFilingOrgAmtOther Compensation Rltd OrgsOtherCompensationRltdOrgsAmtDeferred Compensation Flng OrgDeferredCompensationFlngOrgAmtDeferred Comp Rltd OrgsDeferredCompRltdOrgsAmtNontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmtNontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmtTotal Compensation Filing OrgTotalCompensationFilingOrgAmtTotal Compensation Rltd OrgsTotalCompensationRltdOrgsAmtComp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmtComp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
Andrew Weyrich PhD
President and CEO$595,766$0$168,000$0$54,867$0$37,655$0$13,108$0$869,396$0$0$0
Judith James
EVP and Chief Medical Officer$457,533$0$10,225$0$408,890$0$132,012$0$7,914$0$1,016,574$0$357,135$0
Adam Cohen
SVP and General Counsel$273,111$0$275$0$52,767$0$60,762$0$7,706$0$394,621$0$0$0
Tim Hassen
VP and Chief Financial Officer$270,262$0$450$0$20,577$0$57,879$0$16,611$0$365,779$0$0$0
Courtney Greenwood
VP of Human Resources$202,964$0$150$0$4,430$0$30,621$0$7,706$0$245,871$0$0$0
Courtney Griffin PhD
VP of Research$296,845$0$125$0$10,450$0$48,594$0$15,236$0$371,250$0$0$0
Lisa Day
VP of Government Relations and Advocacy$206,964$0$0$0$3,117$0$35,827$0$7,706$0$253,614$0$0$0
Penny Voss
VP of Philanthropy and Community Relations$230,192$0$0$0$39,994$0$51,079$0$9,722$0$330,987$0$0$0
Benjamin Miller PhD
Program Chair, Aging and Metabolism$174,684$0$75$0$1,180$0$14,868$0$5,457$0$196,264$0$0$0
Gabriel Pardo MD
Professor Clinical Neurology, Arthritis and Clinical Immunology$408,844$0$0$0$2,017$0$37,864$0$15,236$0$463,961$0$0$0
Lijun Xia PhD
Program Chair, Cardiovascular Biology$263,493$0$0$0$40,814$0$59,683$0$5,269$0$369,259$0$0$0
Patrick Gaffney MD
Program Chair, Genes and Human Disease$264,384$0$0$0$13,267$0$40,508$0$15,236$0$333,395$0$0$0
Chelsea Berkley MD
Clinical Assistant Professor, Arthritis and Clinical Immunology$250,227$0$0$0$587$0$25,289$0$5,269$0$281,372$0$0$0
Florea Lupu PhD
Professor, Cardiovascular Biology$319,973$0$0$0$23,000$0$36,219$0$4,780$0$383,972$0$0$0
Yang Mao-Draayer PhD
Professor Clinical Neurology, Arthritis and Clinical Immunology$252,235$0$0$0$38,252$0$23,467$0$9,425$0$323,379$0$0$0
Joel Guthridge PhD
Associate Professor, Arthritis and Clinical Immunology$224,539$0$0$0$27,500$0$26,032$0$5,269$0$283,340$0$0$0
Swapan Nath PhD
Professor, Arthritis and Clinical Immunology$271,725$0$0$0$37,037$0$33,938$0$9,652$0$352,352$0$0$0

Supplemental Information Detail SupplementalInformationDetail (6 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
Schedule J, Part I, Line 1a First-class or charter travelFirst class travel is allowed for the CEO to allow him to accomplish work related to tasks while traveling.
Schedule J, Part I, Line 1a Travel for companionsTravel for companions is allowed in certain limited circumstances where the companion's presence has a benefit to the Foundation but does not qualify as a business expense under IRS rules. In those limited cases the companion's travel expenses are treated as taxable compensation.
Schedule J, Part I, Line 1a Tax indemnification and gross-up paymentsThe Foundation's policy is to provide gross-up payments for all employee relocation expenses.
Schedule J, Part I, Line 4b Supplemental nonqualified retirement planThe Board of the Foundation periodically uses non-qualified retirement plans as a retention tool. The amount reported is the amount vested in the 457(f) plan. The remaining amount of the plan is not vested and is subject to substantial risk of forfeiture.
Schedule J, Part I, Line 7 Non-fixed paymentsThe President receives an annual bonus that is determined by leadership of the board of directors based on performance. The bonus is considered as a portion of total compensation and is subject to the review process previously described.
Schedule J, Part I, Line 3Compensation for the CEO is determined by leadership of the board of directors based on comparability data from widely accepted peer benchmarking surveys that are segmented by region and size of entity.

Schedule K IRS990ScheduleK

Tax Exempt Bonds Issues TaxExemptBondsIssuesGrp

FieldValueIRS element (for citing)
Bond ReferenceABondReferenceCd

Issuer Name IssuerName

FieldValueIRS element (for citing)
Business Name Line1Oklahoma Industries Authority Revenue Bonds (OMRF Project) Series 2016BusinessNameLine1Txt
FieldValueIRS element (for citing)
Bond Issuer EIN736194355BondIssuerEIN
CUSIP000000000CUSIPNum
Bond Issued2016-07-13BondIssuedDt
Issue Price$29,535,000IssuePriceAmt
PurposeRefunding of prior year 2008 bondPurposeDesc
DefeasedfalseDefeasedInd
On Behalf Of IssuerfalseOnBehalfOfIssuerInd
Pool FinancingfalsePoolFinancingInd

Tax Exempt Bonds Proceeds TaxExemptBondsProceedsGrp

FieldValueIRS element (for citing)
Bond ReferenceABondReferenceCd
Retired$24,770,000RetiredAmt
Bond Defeased$0BondDefeasedAmt
Total Proceeds$29,535,000TotalProceedsAmt
In Reserve Fund$2,953,564InReserveFundAmt
Capitalized Interest$0CapitalizedInterestAmt
Refunding Escrow$26,315,325RefundingEscrowAmt
Issuance Costs From Proceeds$266,175IssuanceCostsFromProceedsAmt
Credit Enhancement$0CreditEnhancementAmt
Working Capital Expenditures$0WorkingCapitalExpendituresAmt
Capital Expenditures$0CapitalExpendituresAmt
Other Spent Proceeds$0OtherSpentProceedsAmt
Unspent$0UnspentAmt
Substantial Completion2016SubstantialCompletionYr
Refunding Tax Exempt BondsfalseRefundingTaxExemptBondsInd
Refunding Taxable BondsYes (true)RefundingTaxableBondsInd
Final Allocation MadeYes (true)FinalAllocationMadeInd
Adequate Books And Rec MaintYes (true)AdequateBooksAndRecMaintInd

Tax Exempt Bonds Private Bus Use TaxExemptBondsPrivateBusUseGrp

FieldValueIRS element (for citing)
Bond ReferenceABondReferenceCd
Owning Bond Financed PropertyfalseOwningBondFinancedPropertyInd
Any Lease ArrangementsfalseAnyLeaseArrangementsInd
Mgmt Contract Bond Fincd PropfalseMgmtContractBondFincdPropInd
Engage Bond Counsel ContractsfalseEngageBondCounselContractsInd
Any Research AgreementsYes (true)AnyResearchAgreementsInd
Engage Bond Counsel ResearchYes (true)EngageBondCounselResearchInd
Private Bus Use By Others0.0044PrivateBusUseByOthersPct
Private Bus Concerning UBI0.0PrivateBusConcerningUBIPct
Total Private Business Use0.0044TotalPrivateBusinessUsePct
Bond Iss Meet Prvt Sec Pymt TestfalseBondIssMeetPrvtSecPymtTestInd
Change In Use Bond Financed PropfalseChangeInUseBondFinancedPropInd
Change In Use Bond Financed Prop0ChangeInUseBondFinancedPropPct
Remedial Action TakenfalseRemedialActionTakenInd
Procs Nonqualified Bond RemdtdYes (true)ProcsNonqualifiedBondRemdtdInd

Tax Exempt Bonds Arbitrage TaxExemptBondsArbitrageGrp

FieldValueIRS element (for citing)
Bond ReferenceABondReferenceCd
Form8038 T FiledfalseForm8038TFiledInd
Rebate Not Due YetfalseRebateNotDueYetInd
Exception To RebatefalseExceptionToRebateInd
No Rebate DueYes (true)NoRebateDueInd
Variable Rate IssuefalseVariableRateIssueInd
Hedge Identified In Bks And RecfalseHedgeIdentifiedInBksAndRecInd
Term Of Hedge0TermOfHedgePct
Superintegrated HedgefalseSuperintegratedHedgeInd
Hedge TerminatedfalseHedgeTerminatedInd
Gross Proceeds Invested In GICfalseGrossProceedsInvestedInGICInd
Term Of GIC0TermOfGICPct
Regulatory Safe Harbor StsfdfalseRegulatorySafeHarborStsfdInd
Gross Proceeds InvestedfalseGrossProceedsInvestedInd
Written Proc To Monitor ReqsYes (true)WrittenProcToMonitorReqsInd

Procedures Corrective Action ProceduresCorrectiveActionGrp

FieldValueIRS element (for citing)
Bond ReferenceABondReferenceCd
Procedures Corrective ActionYes (true)ProceduresCorrectiveActionInd

Supplemental Information Detail SupplementalInformationDetail (2 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
Schedule K, Part I 07/13/2016 29535000 Oklahoma Industries AuthorityIn July 2016, the Foundation entered into advanced refinancing of the Series 2008 bonds. The Foundation issued $43,955,000 of OIA Series 2008 Revenue Bonds (the "Series 2008 Bonds") dated July 1, 2008; the proceeds from this bond were used to construct and equip a new research facility. The Series 2008 Bonds were defeased when the Foundation issued $29,535,000 of OIA Series 2016 Revenue Bonds (the "Series 2016 Bonds") dated July 13, 2016. The Series 2016 Bonds mature on July 1, 2026 and bear interest at the stated rate of 1.81% per annum. Payments of principal and interest began January 1, 2017 and are due January 1st and July 1st of each year. The Series 2016 Bond agreements also require maintenance of a reserve fund which is included in investments in the accompanying statement of financial position. This amount was $2,953,500 as of June 30, 2025.
Schedule K, Part IV, Line 2c COLUMN AIssuer name: Oklahoma Industries Authority Revenue Bonds (OMRF Project) Series 2016 The calculation for computing no rebate due was performed on 07/01/2021

Schedule M IRS990ScheduleM

Securities Publicly Traded SecuritiesPubliclyTradedGrp

FieldValueIRS element (for citing)
Contribution18ContributionCnt
Noncash Contributions Rpt F990$476,585NoncashContributionsRptF990Amt
Method Of Determining RevenuesMarket valueMethodOfDeterminingRevenuesTxt
FieldValueIRS element (for citing)
Form8283 Received0Form8283ReceivedCnt
Any Property That Must Be HeldfalseAnyPropertyThatMustBeHeldInd
Review Process Unusual NC GiftsYes (true)ReviewProcessUnusualNCGiftsInd
Third Parties UsedYes (true)ThirdPartiesUsedInd

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceSchedule M, Part I, Line 32b Third parties used to solicit, process, or sell noncash contributionsFormAndLineReferenceDesc
ExplanationThe Foundation contracts with a service organization who solicits the donation of vehicles. The service organization is responsible for communication with the donor as well as the selling process. The Foundation receives a check for 80% of the proceeds from the sale of the vehicle.ExplanationTxt

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (12 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
Form 990, Part III, Line 4a-4c Description of program services(Expenses $ 48,805,337 including grants of $)(Revenue $ 38,720,279) Other program services include departments such as Cell Cycle and Cancer Biology, Genes and Human Disease, Center for Biomedical Data Sciences and other scientific and research support services.
Form 990, Part VI, Line 1a Delegate broad authority to a committeeThe Foundation's Board of Directors has delegated all of its powers to the Foundation's Executive Committee, except as follows: establish the overall policies and direction of the Foundation, appoint the members of the Executive Committee, elect and remove the Chair of the Board of Directors, amend the Bylaws and the Certificate of Incorporation of the Foundation, and appoint special committees to the Board of Directors. The Board of Directors may at any time amend or revoke this delegation of powers.
Form 990, Part VI, Line 11b Review of form 990 by governing bodyThe Form 990 is prepared by the Foundation, internally reviewed by the CFO. The Form 990-T is externally reviewed by the tax department of a public accounting firm. A summary of the Form 990 is presented for review to the Executive Committee. Subsequent to that review, the Form 990 with all supplemental schedules is made available to all members of the board of directors for review and comment prior to filing.
Form 990, Part VI, Line 12c Conflict of interest policyEach director, officer and key employee is annually provided with a copy of the Foundation's conflict of interest policy. Each of these individuals is annually provided with a questionnaire regarding potential conflicts and required to disclose any potential conflict that he or she might have. In addition, each of these individuals must annually sign a statement affirming that he or she has; received a copy of the conflicts of interest policy, read and understood the policy and agrees to comply with the policy. Once the Foundation has collected annual disclosure statements from all directors, officer and key employees, the Foundation's Governance Committee reviews such information to identify situations in which a potential conflict exists and is material. If a potential material conflict is identified, the committee analyzes whether the contemplated transaction may be authorized as just, fair, and reasonable to the Foundation. The Governance Committee then makes a recommendation to the Foundations' Executive Committee regarding the management of all potential conflicts it has identified. The final decision as to the approval and , where applicable, management of all such potential conflicts rests in the sole discretion of the Executive Committee, which makes such decisions based upon the welfare of the Foundation and the advancement of its purpose. The recommendations of the Governance Committee and decisions of the Executive Committee are documented in the respective minutes of these Committees' regular meetings.
Form 990, Part VI, Line 15a Process to establish compensation of top management officialCompensation for officers and key employees is determined and evaluated in May of each year by the executive committee of the board of directors based on comparability data from widely accepted peer bench marking salary surveys that are segmented by region and size of entity.
Form 990, Part VI, Line 15b Process to establish compensation of other employeesCompensation for officers and key employees is determined and evaluated in May of each year by the executive committee of the board of directors based on comparability data from widely accepted peer bench marking salary surveys that are segmented by region and size of entity.
Form 990, Part VI, Line 18 How forms are made available to the publicThe Foundation's Form 990 for the last three years are publicly available on the Foundation's website, as well as on Candid and other nonprofit databases. Form 1023, 990, and 990-T are provided upon request.
Form 990, Part VI, Line 19 Required documents available to the publicThe Foundation's governing documents, conflict of interest policy, and financial statements are provided upon request and are publicly available on the Foundation's website.
Form 990, Part XI, Line 9Includes change in fair value of funds held in trust by others of $7,618,096 as well as pension related changes other than net periodic pension costs of $(119,782).
Form 990, Part XI, Line 9 Other changes in net assets or fund balancesCHANGES IN FAIR VALUE OF FUNDS HELD IN TRUST - 7618096; PENSION RELATED CHANGES OTHER THAN NET PERIODIC PENSION COSTS - -119782; Total - 7498314;
Schedule F, Part I, Line 3Program service activity in all regions includes scientists attending and/or speaking at scientific conferences and collaborations. OMRF does not maintain ongoing operations in foreign jurisdictions however the Foundation's scientists do travel to various scientific conferences in other countries to share in scientific discoveries, as well as, to learn from other scientists across the world.
Form 990, Part VI Section A, Line 2The Foundation currently has 62 directors, many of whom are business leaders and members of prominent families in the State of Oklahoma. The Foundation believes there are multiple business relationships between and among board members and families of Board members, but the Foundation review of signed conflict of interest disclosures from all board members and of the Foundation's ledger accounts indicated there are no such relationships that would impair the fiduciary duties of any director to the Foundation.

Schedule R IRS990ScheduleR

Id Disregarded Entities IdDisregardedEntitiesGrp

Disregarded Entity Name DisregardedEntityName

FieldValueIRS element (for citing)
Business Name Line1Culbertson Plaza LLCBusinessNameLine1Txt

US Address USAddress

FieldValueIRS element (for citing)
Address Line1825 NE 13th StreetAddressLine1Txt
CityOklahoma CityCityNm
State AbbreviationOKStateAbbreviationCd
ZIP73104ZIPCd
FieldValueIRS element (for citing)
EIN842527142EIN
Primary ActivitiesManage real property known as the Culbertson Plaza Shopping CenterPrimaryActivitiesTxt
Legal Domicile StateOKLegalDomicileStateCd
Total Income$211,722TotalIncomeAmt
End Of Year Assets$1,373,955EndOfYearAssetsAmt

Direct Controlling Entity Name DirectControllingEntityName

FieldValueIRS element (for citing)
Business Name Line1Oklahoma Medical Research FoundationBusinessNameLine1Txt